1. Ingeniería

 TM
Yew Bio-Pharm Group, Inc.
Profile
Corporate Information
Ticker YEWB | Primary Stock Exchange OTCQB
Address:
294 Powerbilt Avenue
Las Vegas, NV 89148
Phone: 702-487-4683
Fax: 702-832-0202
Web Site:
http://www.yewchina.com
Auditors:
I.R. Contact:
Judy Sfectu
Employees: 74
Shareholders: 1,000
Founded: 2007
Domicile: Nevada
Officers:
Zhiguo Wang Chairman, President, Chief Financial
Officer, Chief Executive Officer & Chief Accounting
Officer
Guifang Qi Secretary
Judy Sfectu Investor Relations Contact
Directors:
Xingming Han
Tong Liu
Hengjiang Pang
Guifang Qi
Zhiguo Wang
Subsidiaries:
Heilongjiang Jinshangjing Bio-Technology
Development Co., Limited
Yew Bio-Pharm Holdings Limited
Overview: This company grows and sells yew trees, and makes and sells yew raw materials used in the
manufacture of traditional Chinese medicine and products made from yew timber in China.
Incorporated: INCORPORATED in Nevada Nov. 5, 2007.
Background: Yew Bio-Pharm Group, Inc., through its subsidiaries, grows and sells yew trees in the People's
Republic of China. The company is involved in the cultivation and sale of yew seedlings and trees to state-owned
enterprises and private businesses for reforestation in Heilongjiang and Jilin provinces; and sale of potted yew
trees to retail customers. It also produces and sells yew raw materials, including branches and leaves of yew
trees for medicinal application in the pharmaceutical industry; and furniture and handicrafts that are made from
yew timber. The company sells its products through a network of distributors. Yew Bio-Pharm Group, Inc. was
incorporated in 2007 and is based in Las Vegas, Nevada.
Stock Data (Capitalization as of: March 31, 2014)
Stock: Preferred $0.001 par | Authorized Shares 10,000,000 | Outstanding Shares None
Stock: Common $0.001 par | Authorized Shares 140,000,000 | Outstanding Shares 150,000,000
Footnote: 1. Excl. 2,125,000 restricted common shares issued July 22, 2014.
Long Term Debt None.
Stockholders (as of December 31, 2013): 1,000
Principal Stockholder: July 7, 2014, Zhiguo Wang and Guifang Qi, husband and wife, together owned or
controlled 64.0% of the Common.
Transfer Agent: Globex Transfer, LLC, Deltona, FL
Additional Notes:
Dividends
Common Stock
Exchange
OTCQB
Year
2014
2013
High
1.1000
1.1000
Low
0.1100
0.1000
Footnote:
This information should not be used for determining a company’s manual exemption status. Only the listing from Corporation Records should be used for that purpose. This report is for informational purposes and should not be
considered a solicitation to buy or sell any security nor is this report considered investment advice. Neither S&P Capital IQ nor any other party guarantees its accuracy or makes warranties regarding results from its usage. S&P
Capital IQ receives compensation from the issuer or an agent thereof for initiating coverage, and for distribution including licensed redistribution of this report, and/or for inclusion in other S&P Capital IQ publications, generally in
amounts up to U.S. $3,995. per year. Redistribution is prohibited without written permission.
Page 1
TM
| February 05, 2015
Yew Bio-Pharm Group, Inc. | Ticker YEWB | Primary Exchange OTCQB
Annual Report
IncomeStatement as of Dec. 31 (Thou. US DOLLAR)
Revenues
Cost of revenues
Operating exps.
Interest income
Other income (expense)
Net income
Share earns. basic
Share earns. diluted
2013
7,440
2,407
1,135
1
1
3,900
0.08
0.08
2012
6,728
1,279
3,244
2
(1)
2,206
0.05
0.05
BalanceSheet as of Dec. 31 (Thou. US DOLLAR)
Assets:
Cash & equiv.
Accts. rec., net
Inventories
Prepayments & other curr. assets
Tot. curr. assets
Inventories
Net property
Land use rights and yew forests assets
Total assets
Liabilities:
Due to related parties
Accts. pay.
Accrued expenses and other payables
Taxes payable
Tot. curr. liabs.
Com. stk. p.$0.001
Paid-in cap.
Retained earns.
Statutory reserves
Accumulated other comprehensive income
Total liabs.
This listing from S&P Capital IQ Market Access Program including Corporate Records should not be used for determining a company's manual exemption
status. Only the listing from Corporation Records should be used for that purpose. Redistribution is prohibited without written permission.
2013
2012
1,160
797
1,089
36
3,082
10,245
1,033
20,954
35,314
387
1,008
991
60
2,446
9,382
886
15,328
28,042
4,851
48
1
199
6
254
50
10,396
13,182
2,179
1,981
28,042
137
10
4,998
50
8,058
16,664
2,597
2,947
35,314
Page 2